Body mass index trajectories in pediatric multiple sclerosis

J Nicholas Brenton1, Emma Woolbright2, Christina Briscoe-Abath3

  • 1Pediatric Neurology, Department of Neurology, University of Virginia, Charlottesville, VA, USA.

Insights

Children with multiple sclerosis show higher body mass index (BMI) z-scores years before diagnosis. This indicates increased overweight prevalence in pediatric multiple sclerosis patients from early childhood.

Area of Science:

  • Pediatric Neurology
  • Growth and Development
  • Chronic Disease Epidemiology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with a significant impact on pediatric populations.
  • Understanding growth patterns in children with MS is crucial for early identification and management.
  • Previous research has not fully characterized the growth trajectories of children who develop MS.

Purpose of the Study:

  • To compare the growth trajectories of children who develop multiple sclerosis (MS) with those of typically developing peers.
  • To assess body mass index (BMI) z-scores in pediatric MS cases relative to matched controls and Centers for Disease Control (CDC) normative data.
  • To investigate BMI differences in relation to the age of MS onset.

Main Methods:

  • A case-control study involving 40 pediatric MS patients and 120 typically developing controls, matched for age, sex, ethnicity, and socioeconomic status.
  • Collection of weight, height, and BMI data for all participants.
  • Conversion of BMI values to z-scores using CDC reference data for comparison across cohorts and in relation to MS onset.

Main Results:

  • Pediatric MS patients exhibited significantly higher BMI z-scores compared to both typically developing peers and CDC normative values.
  • These significant BMI differences were observed starting from 4 years of age, predating clinical MS onset (median onset age 15 years).
  • Height trajectories were comparable between the MS cohort, control group, and CDC standards.

Conclusions:

  • Body mass index is markedly elevated in children with MS, beginning in early childhood, years prior to clinical disease manifestation.
  • Pediatric MS patients are significantly more overweight at diagnosis than their typically developing counterparts.
  • Elevated BMI trajectories may serve as an early indicator or risk factor in the development of pediatric multiple sclerosis.
Abstract

Related Concept Videos

Reduced Mass Coordinates: Isolated Two-body Problem01:12

Reduced Mass Coordinates: Isolated Two-body Problem

In classical mechanics, the two-body problem is one of the fundamental problems describing the motion of two interacting bodies under gravity or any other central force. When considering the motion of two bodies, one of the most important concepts is the reduced mass coordinates, a quantity that allows the two-body problem to be solved like a single-body problem. In these circumstances, it is assumed that a single body with reduced mass revolves around another body fixed in a position with an...
2.4K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.0K
Atomic Mass01:52

Atomic Mass

Atoms — and the protons, neutrons, and electrons that compose them — are extremely small. For example, a carbon atom weighs less than 2 × 10−23 g. When describing the properties of tiny objects such as atoms, we use appropriately small units of measure, such as the atomic mass unit (amu). The amu was originally defined based on hydrogen, the lightest element, then later in terms of oxygen. Since 1961, it has been defined with regard to the most abundant isotope of carbon, atoms of which...
69.9K
Molar Mass01:54

Molar Mass

The identity of a substance is defined not only by the types of atoms or ions it contains but by the quantity of each type of atom or ion. For example, water, H2O, and hydrogen peroxide, H2O2, are alike in that their respective molecules are composed of hydrogen and oxygen atoms. However, because a hydrogen peroxide molecule contains two oxygen atoms, as opposed to the water molecule, which has only one, the two substances exhibit very different properties.
86.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276